A new COVID-19 testing facility has opened at YWG, operated by Canadian medical research and biotech company CardiAI. The facility is intended to assist air travellers in fulfilling their testing requirements for travel at “a fair market price.”
CardiAI specializes in healthcare technology and development centered on patient care and medical services. The Canadian company is currently operating COVID-19 testing laboratories in Calgary, Vancouver, and Mississauga to offer PCR, antibody and rapid antigen tests.
"CardiAI's new testing site at Winnipeg Richardson International Airport offers travellers a convenient location to obtain COVID-19 tests needed for travel," said Barry Rempel, President and CEO of Winnipeg Airports Authority.
"The pandemic has changed our industry and the addition of CardiAI assists travellers in meeting current testing requirements for international travel at a fair market price, while also opening the door for future services to serve the community."
The new facility is located inside the terminal building on the Departures Level at the far east end past the airline check-in counters. The site will support an array of different COVID-19 tests, including some with same-day results available, and will be open for walk-ins as well as scheduled appointments.
CardiAI will be open seven days a week inside the terminal between 3:30 a.m. to 2:00 p.m. for rapid antigen testing at CAD $59 per test plus GST and Monday to Friday for RT-PCR testing at CAD $149 per test plus GST.
Dr. Anmol Kapoor, Founder and CEO of CardiAI, said, "We look forward to playing a critical role in helping those looking to travel receive the results they need to enter select regions, gain peace of mind and help us continue to work together to get ahead of the curve of this virus."
For more information on CardiAl’s Winnipeg services, visit its web site.
